A small carefully constructed and blinded clinical trial confirms that percutaneous intervention significantly relieves angina in patients with chronic total obstruction.

Aspirin is considered the cornerstone of secondary prevention of coronary artery disease. However, the evidence supporting aspirin was largely generated before the advent of modern pharmacological and ...

For coronary artery disease patients undergoing transcatheter aortic valve implantation (TAVI), waiting to see if ...

The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally ...

IntraSight Plus merges Philips’ technologies, offering co-registration, iFR/FFR physiology, and real-time device ...

Percutaneous coronary intervention (PCI) is increasingly used for revascularization of unprotected left main coronary artery disease. Whether intravascular ultrasonographic (IVUS) guidance during ...

Randomized trials neutral for pump device in complex elective cases, STEMI with reperfusio ...

The first randomized trial to compare standard percutaneous coronary intervention (PCI), also known as coronary angioplasty, with PCI accompanied by the use of a temporary, miniaturized pump to ...

Primary percutaneous coronary intervention, where available, has become the therapy of choice in myocardial reperfusion during ST-elevation myocardial infarction. However, in a significant proportion ...

Please provide your email address to receive an email when new articles are posted on . Despite similar procedural success, percutaneous mitral valve repair for post-MI mitral regurgitation was ...